Author:
Perrone F.,Carlomagno C.,De Placido S.,Lauria R.,Morabito A.,Bianco A. R.
Reference93 articles.
1. Tannock IF, Boyd NF, De Boer G et al. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 1988; 1050–5.
2. Baum M, Priestman T, West RR et al. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. In Mouridsen HT, Palshof T (eds): Breast Cancer — Experimental and Clinical Aspects. Oxford: Pergamon Press 1980; 223–6.
3. Coates A, Gebski V, Bishop JF et al. Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 1987; 317:1490–5.
4. Brunner KW, Sonntag RW, Martz G et al. A controlled study in the use of combined drug therapy for metastatic breast cancer. Cancer 1975; 36:1208–19.
5. Andersen JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 11:710–9.